ObsEva SA to Attend LEERINK Partners Global Healthcare Conference in NYC
(Thomson Reuters ONE) -
ObsEva SA /
ObsEva SA to Attend LEERINK Partners Global Healthcare Conference in NYC
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Geneva, Switzerland - February 03, 2017 - ObsEva SA (ObsEva) announced today
that Ernest LOUMAYE, M.D., Ph.D., CEO and Co-Founder and Tim ADAMS, CFO, will
attend the LEERINK Partners Global Healthcare Conference and hold one-on-one
meetings on February 15 and 16, 2017 at Lotte New York Palace, NYC.
- ends -
About ObsEva SA
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical
development and commercialization of novel therapeutics for serious conditions
that compromise a woman's reproductive health and pregnancy. ObsEva is focused
on providing therapeutic solutions for women between the ages of 15 and 49 who
suffer from reproductive health conditions that affect their quality of life or
ability to conceive, or that complicate pregnancy and the health of newborns.
Through strategic in-licensing and disciplined drug development, ObsEva has
established a late-stage clinical pipeline with development programs focused on
treating endometriosis, uterine fibroids, preterm labor and improving in vitro
fertilization outcomes. ObsEva is listed on The NASDAQ Global Select Market and
is trading under the ticker symbol "OBSV". For more information, please visit
www.ObsEva.com.
MEDIA CONTACT
Liz Bryan
Spectrum Science
lbryan(at)spectrumscience.com
202-955-6222 x2526
COMPANY CONTACT
Delphine Renaud
ObsEva, CEO Office
delphine.renaud(at)obseva.ch
+41 22 552 1550
Press Release:
http://hugin.info/157613/R/2075734/780540.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ObsEva SA via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 03.02.2017 - 13:00 Uhr
Sprache: Deutsch
News-ID 521869
Anzahl Zeichen: 2389
contact information:
Town:
Plan-les-Ouates
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 239 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ObsEva SA to Attend LEERINK Partners Global Healthcare Conference in NYC"
steht unter der journalistisch-redaktionellen Verantwortung von
ObsEva SA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
